What s New in Myeloproliferative Neoplasms? An Update on Polycythemia Vera and Essential Thrombocythemia

What s New in Myeloproliferative Neoplasms? An Update on Polycythemia Vera and Essential Thrombocythemia

Outline the current criteria and methods for the timely diagnosis and accurate risk stratiícation of PV and ET Assess the recent evidence for the eïcacy and safety of novel therapies for PV and ET Design treatment plans that incorporate both recently approved/emerging agents and established therapies for PV and ET patients in the community setting Propose ways to employ guideline adherent strategies in community practice while accounting for the characteristics and preferences of individual patients

  • Provider:Medical Education Resources
  • Activity Link: https://mycme.com
  • Start Date: 2024-12-01 06:00:00
  • End Date: 2024-12-01 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: Source: Incyte Corporation - Amount: 50000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.